Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

De-Yi Yang

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitorsWensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseasesVinay M Girijavallabhan, Lei Chen, Chaoyang Dai, et al.
Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bioorganic & Medicinal Chemistry Letters|April 15, 2018
MK-8325: A silyl proline-containing NS5A inhibitor with pan-genotype activity for treatment of HCVAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2010
Biaryl substituted hydantoin compounds as TACE inhibitorsWensheng Yu, Ling Tong, Seong Heon Kim, et al.
Bioorganic & Medicinal Chemistry Letters|July 18, 2016
Matched and mixed cap derivatives in the tetracyclic indole class of HCV NS5A inhibitorsMichael P Dwyer, Kerry M Keertikar, Lei Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2016
Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activityWensheng Yu, Craig A Coburn, De-Yi Yang, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of hydantoin TACE inhibitorsWensheng Yu, Zhuyan Guo, Peter Orth, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2016
Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Bioorganic & Medicinal Chemistry Letters|June 11, 2016
Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742Wensheng Yu, Craig A Coburn, Anilkumar G Nair, et al.
Bioorganic & Medicinal Chemistry Letters|November 26, 2010
Novel TNF-α converting enzyme (TACE) inhibitors as potential treatment for inflammatory diseasesVinay M Girijavallabhan, Lei Chen, Chaoyang Dai, et al.
Journal of Medicinal Chemistry|February 18, 2014
The discovery of N-((2H-tetrazol-5-yl)methyl)-4-((R)-1-((5r,8R)-8-(tert-butyl)-3-(3,5-dichlorophenyl)-2-oxo-1,4-diazaspiro[4.5]dec-3-en-1-yl)-4,4-dimethylpentyl)benzamide (SCH 900822): a potent and selective glucagon receptor antagonistDuane DeMong, Xing Dai, Joyce Hwa, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2016
Discovery of silyl proline containing HCV NS5A inhibitors with pan-genotype activity: SAR developmentAnilkumar G Nair, Qingbei Zeng, Oleg Selyutin, et al.
Pageof 3